Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Methods for Assessing Mitochondrial Function in Diabetes
Perry, Christopher G. R. , Kane, Daniel A. , Lanza, Ian R. , Neufer, P. Darrell , Lanza, Ian R

Diabetes | March 21, 2013 | Volume: 62 | Issue: 4 | Pages: 1041-1053

10.2337/db12-1219 | PMID 23520284 Get It

A growing body of research is investigating the potential contribution of mitochondrial function to the etiology of type 2 diabetes. Numerous in vitro, in situ, and in vivo methodologies are available to examine various aspects of mitochondrial function, each requiring an understanding of their principles, advantages, and limitations. This review provides investigators with a critical overview of the strengths, limitations and critical experimental parameters to consider when selecting and conducting studies on mitochondrial function. In vitro (isolated mitochondria) and in situ (permeabilized cells/tissue) approaches provide direct access to the mitochondria, allowing for study of mitochondrial bioenergetics and redox function under defined substrate conditions. Several experimental parameters must be tightly controlled, including assay media, temperature, oxygen concentration, and in the case of permeabilized skeletal muscle, the contractile state of the fibers. Recently developed technology now offers the opportunity to measure oxygen consumption in intact cultured cells. Magnetic resonance spectroscopy provides the most direct way of assessing mitochondrial function in vivo with interpretations based on specific modeling approaches. The continuing rapid evolution of these technologies offers new and exciting opportunities for deciphering the potential role of mitochondrial function in the etiology and treatment of diabetes.
Fulminant Demyelinating Diseases
Rahmlow, Megan R., Kantarci, Orhun H.

The Neurohospitalist | March 21, 2013 | Volume: 3 | Issue: 2 | Pages: 81-91

10.1177/1941874412466873 | PMID 23983890 Get It

Fulminant demyelinating disease is a heading that covers acute disseminated encephalomyelitis and its variant acute hemorrhagic leukoencephalitis (Hurst disease), severe relapses of multiple sclerosis (MS), variants of MS (tumefactive MS, Marburg variant, Balo concentric sclerosis, myelinoclastic diffuse sclerosis), and neuromyelitis optica-spectrum disorders associated with aquaporin autoimmunity. These categories of inflammatory demyelinating disease often prompt hospital admission and many necessitate intensive care monitoring due to the aggressive nature of the illness and associated neurologic morbidity. In this review, we highlight the discriminating clinical, radiographic, and pathologic features of these disorders. Acute management is often accomplished with use of high-dose intravenous steroids and plasma exchange. Aggressive disease may respond to immunosuppression. Prognosis for recovery varies among the disorders but most patients improve. Factors influencing outcome are also discussed.
Paraneoplastic and Other Autoimmune Disorders of the Central Nervous System
McKeon, Andrew , McKeon, Andrew

The Neurohospitalist | March 21, 2013 | Volume: 3 | Issue: 2 | Pages: 53-64

10.1177/1941874412453339 | PMID 23983888 Get It

As a result of the burgeoning growth of disease-specific neural autoantibody markers available for diagnostic patient evaluation, there has been increasing awareness of autoimmune central nervous system (CNS) disorders in hospital practice. Hospital-based neurologists have also taken great interest in these disorders since many occur in the setting of an occult systemic cancer which can be detected and treated at an early stage, and many affected patients are responsive to immunotherapy. Associated neurological disorders are typically subacute in onset, some are common or classic (eg, limbic encephalitis, cerebellar degeneration), but others have atypical or multifocal presentations. For patients with a suspected paraneoplastic disorder, many and costly oncological evaluations may be required for diagnosis. Comprehensive serological and cerebrospinal fluid (CSF) evaluation for neural autoantibodies may permit a focused cancer evaluation (eg, antineuronal nuclear antibody type 1 [ANNA-1] is associated with small cell lung carcinoma), and in some circumstances may indicate the likelihood of a good response to therapy (eg, voltage-gated potassium channel complex antibody) or poor neurological prognosis (eg, purkinje cell cytoplasmic antibody type 1 [antiYo]). Positron-emission tomography–computed tomography (PET-CT) imaging of trunk may increase the diagnostic yield for certain cancers where other modalities have been negative. For some patients, rapid treatment with immunotherapy may facilitate marked improvement, or full recovery; multiple sequential trials of one or more of steroids, intravenous immunoglobulin or plasma exchange, or combination therapy are often required. For patients with N-methyl-d-aspartate receptor antibody encephalitis, early treatment with immunosuppressants and weeks or months of supportive intensive care may additionally be required. One or more of clinical examination, electroencephalogram (including video telemetry), and imaging provide objective parameters to which posttreatment outcomes can be compared.
Faculty Opinions recommendation of The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.
Midthun, David E.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 21, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717989834.793473014 Get It

Faculty Opinions recommendation of Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.
Midthun, David E.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 21, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.13827959.793473016 Get It

Faculty Opinions recommendation of Reduced lung-cancer mortality with low-dose computed tomographic screening.
Midthun, David E.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 21, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717989836.793473021 Get It

Faculty Opinions recommendation of Early Lung Cancer Action Project: overall design and findings from baseline screening.
Midthun, David E.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 21, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717989835.793473018 Get It

Faculty Opinions recommendation of The National Lung Screening Trial: overview and study design.
Midthun, David E.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 21, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717989837.793473023 Get It

Faculty Opinions recommendation of Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
Midthun, David E.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 21, 2013 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.717989846.793473033 Get It